Calafos

Medicinal product

(Invented) name

Calafos

Active substance (s)

Lantanas

Strength

750 mg

Pharmaceutical form

kramtomosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AE03, Lanthanum carbonate

Marketing authorisation holder

Viatris Limited, Airija

Date of authorisation

2021-03-05

Date of renewal

2025-07-18

Documents

4702_Calafos_perr2025-07-18.docx

4702_pakuotes lapelis_2025-07-18.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

DE/H/5577/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Lantanas	750 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106139	92240	1092240	buteliukas	N15		Receptinis	LT/1/21/4702/001	Netiekiama	-	-	No	-	-
106140	92241	1092241	buteliukas	N90 (6x15)		Receptinis	LT/1/21/4702/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-07-18	Perregistruotas
2021-03-05	Registruotas